METHODS FOR TREATMENT OF PEDIATRIC METABOLIC SYNDROME
- 专利权人:
- АМАРИН ФАРМАСЬЮТИКАЛЗ АЙРЛЭНД ЛИМИТЕД (IE)
- 发明人:
- СОНИ, Пареш (US)
- 申请号：
- RU2020125675
- 公开号：
- RU2020125675A
- 申请日:
- 2013.06.27
- 申请国别(地区):
- RU
- 年份:
- 2020
- 代理人:
- 摘要：
- In various embodiments, the present invention provides methods of treating and/or preventing pediatric metabolic syndrome comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. In one embodiment, the method comprises administering about 1 g to about 4 g of ethyl eicosapentaenoate per day. In one embodiment, the composition contains not more than 10%, by weight, docosahexaenoic acid or derivative thereof, substantially no docosahexaenoic acid or derivative thereof, or no docosahexaenoic acid or derivative thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- METHODS OF TREATING PEDIATRIC METABOLIC SYNDROME
- Methods of treating pediatric metabolic syndrome
- DOCOSAHEXAENOIC ACID ETHYL ESTERS AND/OR ITS DERIVATIVES FOR PREVENTION AND/OR TREATMENT OF AGE-RELATED MACULAR DEGENERATION
- Use of the prodrug acid ethyl ester of N - (3-methoxy-3-oxopropyl 3-carboxy - 1 -) - (4S) - P - fenilfenilmetil) - 4 - amino - (2R) - metilbutanoico or acid n - (3-methoxy-3-oxopropyl 3-carboxy - 1 -) - (4S) - P - (2R) - fenilfenilmetil) - 4 - amino - metilbutanoico, inhibitors of NEP with Valsartan in treating Heart Failure with pool Ion preserved ejection.
- Ethyl-3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1- methyl-1h-benzimidazol-5-carbonyl)-pyridine-2-yl-amino]-propionic acid ethyl ester methane sulphonate in crystalline form ii, pharmaceutical composition comprising it and uses thereof for preparing pharmaceutical compositions which are suitable for the post-operative prophylaxis of deep vein thrombosis and the prevention of stroke and process for the preparation thereof
